189 related articles for article (PubMed ID: 7509897)
1. Pharmacologic properties of a novel Ca2+ entry blocker, AJ-2615, in vitro.
Okamura H; Fujitani B; Furukawa K; Une T; Nukuda T; Komiya M; Kurokawa M
J Cardiovasc Pharmacol; 1993 Dec; 22(6):804-9. PubMed ID: 7509897
[TBL] [Abstract][Full Text] [Related]
2. Studies on calcium antagonistic and alpha 1-adrenergic receptor blocking activities of monatepil maleate, its metabolites and their enantiomers.
Honda Y; Masuda Y; Yoshida T; Sato F; Kurokawa M; Hosoki K
Arzneimittelforschung; 1995 Oct; 45(10):1057-60. PubMed ID: 8595057
[TBL] [Abstract][Full Text] [Related]
3. Mechanism of vascular relaxation by thaligrisine: functional and binding assays.
Tur R; Magraner J; Catret M; Elorriaga M; Ivorra MD; D'Ocon P; Bermejo A; Cabedo N; Cortes D; Anselmi E
Life Sci; 2000 Aug; 67(13):1535-48. PubMed ID: 10983849
[TBL] [Abstract][Full Text] [Related]
4. Cerebrovascular selectivity and vasospasmolytic action of the novel calcium antagonist (+/-)-(E)-1-(3-fluoro-6, 11-dihydrodibenz[b,e]oxepin-11-yl)-4-(3-phenyl-2-propenyl)-piperazine dimaleate in isolated cerebral arteries of the rabbit and dog.
Minato H; Hashizume M; Masuda Y; Fujitani B; Hosoki K
Arzneimittelforschung; 1997 Apr; 47(4):339-46. PubMed ID: 9150852
[TBL] [Abstract][Full Text] [Related]
5. Vasorelaxing effect in rat thoracic aorta caused by fraxinellone and dictamine isolated from the Chinese herb Dictamnus dasycarpus Turcz: comparison with cromakalim and Ca2+ channel blockers.
Yu SM; Ko FN; Su MJ; Wu TS; Wang ML; Huang TF; Teng CM
Naunyn Schmiedebergs Arch Pharmacol; 1992 Mar; 345(3):349-55. PubMed ID: 1377790
[TBL] [Abstract][Full Text] [Related]
6. Investigations of the dual contractile/relaxant properties showed by antioquine in rat aorta.
Ivorra MD; Lugnier C; Catret M; Anselmi E; Cortes D; D'Ocon P
Br J Pharmacol; 1993 Jun; 109(2):502-9. PubMed ID: 8358549
[TBL] [Abstract][Full Text] [Related]
7. Effects of a novel smooth muscle relaxant, KT-362, on contraction and cytosolic Ca2+ level in the rat aorta.
Sakata K; Karaki H
Br J Pharmacol; 1991 Jan; 102(1):174-8. PubMed ID: 1710524
[TBL] [Abstract][Full Text] [Related]
8. Effects of felodipine, nifedipine and verapamil on cytosolic Ca2+ and contraction in vascular smooth muscle.
Hagiwara S; Mitsui M; Karaki H
Eur J Pharmacol; 1993 Mar; 234(1):1-7. PubMed ID: 7682512
[TBL] [Abstract][Full Text] [Related]
9. Multiple actions of glaucine on cyclic nucleotide phosphodiesterases, alpha 1-adrenoceptor and benzothiazepine binding site at the calcium channel.
Ivorra MD; Lugnier C; Schott C; Catret M; Noguera MA; Anselmi E; D'Ocon P
Br J Pharmacol; 1992 Jun; 106(2):387-94. PubMed ID: 1327380
[TBL] [Abstract][Full Text] [Related]
10. Differential effects of calcium antagonists and Bay K 8644 on contractile responses to exogenous noradrenaline and adrenergic nerve stimulation in the rabbit ear artery.
Skärby TV; Högestätt ED
Br J Pharmacol; 1990 Dec; 101(4):961-7. PubMed ID: 1707708
[TBL] [Abstract][Full Text] [Related]
11. Brazilein-induced contraction of rat arterial smooth muscle involves activation of Ca2+ entry and ROK, ERK pathways.
Shen J; Yip S; Wang Z; Wang W; Xing D; Du L
Eur J Pharmacol; 2008 Feb; 580(3):366-71. PubMed ID: 18177858
[TBL] [Abstract][Full Text] [Related]
12. Structurally novel antihypertensive compound, McN-5691, is a calcium channel blocker in vascular smooth muscle.
Flaim SF; Gleason MM; Hedberg A; Shank RP; McCullough JR; Gill A; Damiano BP; Brannan MD; Carson JR
J Pharmacol Exp Ther; 1991 Jan; 256(1):279-88. PubMed ID: 1846419
[TBL] [Abstract][Full Text] [Related]
13. A novel 1,4 dihydropyridine, BAY K 8644, with contractile effects on vascular smooth muscle.
Mikkelsen E; Nyborg NC; Kazda S
Acta Pharmacol Toxicol (Copenh); 1985 Jan; 56(1):44-9. PubMed ID: 2579520
[TBL] [Abstract][Full Text] [Related]
14. Effect of the Ca(2+)-channel agonist Bay K 8644 on the contractile responses in human placental veins.
Barrús MT; Reviriego J; Marín J
J Auton Pharmacol; 1996 Jun; 16(3):161-7. PubMed ID: 8884463
[TBL] [Abstract][Full Text] [Related]
15. L-type Ca2+ channels activation and contraction elicited by myricetin on vascular smooth muscles.
Fusi F; Saponara S; Frosini M; Gorelli B; Sgaragli G
Naunyn Schmiedebergs Arch Pharmacol; 2003 Dec; 368(6):470-8. PubMed ID: 14618297
[TBL] [Abstract][Full Text] [Related]
16. Pharmacological dissection of Ca2+ channels in the rat aorta by Ca2+ entry modulators.
Rico I; Alonso MJ; Salaices M; Marín J
Pharmacology; 1990; 40(6):330-42. PubMed ID: 1700444
[TBL] [Abstract][Full Text] [Related]
17. Effects of Ca2+ antagonists and K+-channel activators on K+-induced contractions in the rat aorta.
Lawson K; Cavero I
J Auton Pharmacol; 1989 Oct; 9(5):329-36. PubMed ID: 2482291
[TBL] [Abstract][Full Text] [Related]
18. Ca2+ buffering action of sarcoplasmic reticulum on Bay k 8644-induced Ca2+ influx in rat femoral arterial smooth muscle.
Asano M; Nomura Y
Eur J Pharmacol; 1999 Jan; 366(1):61-71. PubMed ID: 10064153
[TBL] [Abstract][Full Text] [Related]
19. Calcium channel activation does not increase release of endothelial-derived relaxant factors (EDRF) in rat aorta although tonic release of EDRF may modulate calcium channel activity in smooth muscle.
Spedding M; Schini V; Schoeffter P; Miller RC
J Cardiovasc Pharmacol; 1986; 8(6):1130-7. PubMed ID: 2434737
[TBL] [Abstract][Full Text] [Related]
20. SR 33557, a novel calcium entry blocker. I. In vitro isolated tissue studies.
Polster P; Christophe B; Van Damme M; Houlliche A; Chatelain P
J Pharmacol Exp Ther; 1990 Nov; 255(2):593-9. PubMed ID: 1700816
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
